sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Micafungin

Medicine

Micafungin

Micafungin for Injection is indicated for: Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses in adult and pediatric patients 4 months of age and older.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
  • Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses in adult and pediatric patients 4 months of age and older.
  • Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age.
  • Treatment of Esophageal Candidiasis in adult and pediatric patients 4 months of age and older.
Do not take if
Micafungin for injection is contraindicated in persons with known hypersensitivity to micafungin, any component of micafungin for injection, or other echinocandins.

What it is used for

Micafungin for injection is indicated for:

  • Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses in adult and pediatric patients 4 months of age and older.
  • Treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age.
  • Treatment of Esophageal Candidiasis in adult and pediatric patients 4 months of age and older.
  • Prophylaxis of Candida Infections in adult and pediatric patients 4 months of age and older undergoing hematopoietic stem cell transplantation.

Limitations of Use

  • The safety and effectiveness of micafungin for injection have not been established for the treatment of candidemia with meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age as a higher dose may be needed.
  • Micafungin for injection has not been adequately studied in patients with endocarditis, osteomyelitis and meningoencephalitis due to Candida.
  • The efficacy of micafungin for injection against infections caused by fungi other than Candida has not been established.

Side effects, and when to stop

The following clinically significant adverse reactions are described elsewhere in the labeling:

  • Hypersensitivity Reactions
  • Hematological Effects
  • Hepatic Effects
  • Renal Effects
  • Infusion and Injection Site Reactions

Who should not take it

Micafungin for injection is contraindicated in persons with known hypersensitivity to micafungin, any component of micafungin for injection, or other echinocandins.

Storing it

Storage Conditions

Unopened vials of lyophilized material must be stored at room temperature, 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F).

Store the reconstituted product at 25°C (77°F) [ see Dosage and Administration ( 2.4 )].

Store the diluted solution at 25°C (77°F) [ see Dosage and Administration ( 2.4 )].

Protect from light.

Discard unused portion.

Sterile, Nonpyrogenic, Preservative-free. The container closure is not made with natural rubber latex.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Micafungin; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/micafungin

APA 7th

sofidex. (2026, August 3). Micafungin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/micafungin

AMA 11th

Micafungin. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/micafungin

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.